The report of Deloitte's rapid review reads more like a case to reverse the defunding decision and for the removal of the officials responsible for the administration of federally-funded quality use programs.
Did anyone actually read this report before confirming the decision?
September 16, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The race for the Pharma Cup heats up as teams chase the summit
February 8, 2026 - - Latest News -
The leaders will be thinking about this situation like a game of chess
February 7, 2026 - - Latest News -
TrumpRx launches based on global pricing promise in an insurance-dominated reality
February 7, 2026 - - Latest News -
Queensland launches largest free flu vaccination program in Australia
February 6, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 6 February
February 6, 2026 - - Podcast -
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News

